Search

Your search keyword '"Ceci F"' showing total 644 results

Search Constraints

Start Over You searched for: Author "Ceci F" Remove constraint Author: "Ceci F"
644 results on '"Ceci F"'

Search Results

1. Usefulness of calcaneal quantitative ultrasound stiffness for the evaluation of bone health in HIV-1-infected subjects: comparison with dual X-ray absorptiometry

2. Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysis

5. PSMA-PET vs. conventional imaging for preoperative staging high-risk PCa patients underwent surgery for cN0M0 disease

7. Second line PSMA-targeted salvage treatment in patients with mi N1/M1a-b oligorecurrent PCa

10. Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on PSMA-PET: Results of a Multicenter, European Study

11. [18F]FDG PET/CT: Lung Nodule Evaluation in Patients Affected by Renal Cell Carcinoma

12. Green-Oriented Crowdfunding Campaign: An Explorative Study

13. 68Ga-PSMA PET/CT in prostate cancer

20. Does metastases-direct therapy guided by PSMA PET/CT really improve oncologic outcomes in oligorecurrent prostate cancer patients?

21. The impact of PSMA PET/CT on oncologic outcomes of patients with recurrent prostate cancer: The experience of 3 high-volume European centers

22. The Maximum Standardized Uptake Value in Patients with Recurrent or Persistent Prostate Cancer after Radical Prostatectomy and PSMA-PET-Guided Salvage Radiotherapy – A Multicenter Retrospective Analysis

24. Metastasis-free survival and patterns of distant metastatic disease after PSMA-PET-guided salvage radiotherapy in recurrent or persistent prostate cancer after prostatectomy

25. The impact of PSMA PET/CT on oncologic outcomes of patients with recurrent prostate cancer: the experience of 3 high-volume european centers

26. Does metastases-direct therapy guided by PSMA PET/CT really improve oncologic outcomes in oligorecurrent prostate cancer patients?

27. Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients. risk factors and therapeutic implications

28. A retrospective analysis of the correlation between functional imaging and clinical outcomes in grade 3 neuroendocrine tumors (Nets g3)

29. Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study

30. Assessment of health-related quality of life in patients with advanced prostate cancer current state and future perspectives

31. Topic: Mesh and Prosthesis

32. Recent Innovations & Daily Problems

33. Event-Free survival after 68Ga-PSMA-11 PET/CT in recurrent Hormone-Sensitive Prostate Cancer (HSPC) patients eligible for salvage therapy

34. Oncological outcomes in patients with recurrent prostate cancer staged with PSMA PET/CT: Results from 3 European tertiary centers

36. Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review

38. Re: Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection prior to Radical Prostatectomy and Pelvic Lymph Node Dissection : A Multicenter Prospective Phase 3 Imaging Trial

39. Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future Perspectives

40. Lung uptake detected by 68Ga-PSMA-11 PET/CT in prostate cancer patients with SARS-CoV-2: a case series

41. Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study

42. Inequalities in screening policies and perioperative protection for patients with acute appendicitis during the pandemic: Subanalysis of the ACIE Appy study

45. Metastasis-free survival after salvage radiotherapy for post-operative prostate cancer patients in the PSMA PET/CT era – a multicenter analysis

46. How Distributed Ledger Technology Can Influence Trust Improving Data Sharing in Collaborative Networks

47. External validation of a nomogram for predicting 68GA-PSMA PET/CT detection rate in patients with prostate cancer recurrence: a clinical tool to guide physicians before suggesting 68GA-PSMA PET/CT

48. PO-1335 PSMA-PET impact on post-prostatectomy recurrencies multidisciplinary management: focus on RT

50. O02 - Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on PSMA-PET: Results of a Multicenter, European Study

Catalog

Books, media, physical & digital resources